Research Frontiers Reports First Quarter 2024 Financial Results and Will Host a Conference Call at 5:30p.m. Today
Research Frontiers Inc. (Nasdaq: REFR) released its first quarter 2024 financial results, reporting fee income increase by over 26% from the previous year, expecting revenue growth across all market segments, with a strong cash position and no debt, ensuring sufficient working capital for the next five years. A conference call will be held to discuss these results and recent developments.
Fee income increased by over 26% in the first quarter of 2024 compared to the same period last year.
The Company anticipates revenue growth in all market segments due to the introduction of new products utilizing its SPD-SmartGlass technology.
Research Frontiers had cash and cash equivalents of approximately $2.1 million and working capital of $2.9 million as of March 31, 2024.
The Company has no debt and expects to have sufficient working capital for at least the next five years of operations.
- None.
WOODBURY, N.Y., May 09, 2024 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced its financial results for its first quarter of 2024. Management will host a conference call today at 5:30 p.m. Eastern Time to discuss its financial and operating results as well as recent developments.
| • | Who: Joseph M. Harary, President & CEO | |
| • | Date/Time: Thursday, May 9, 2024, 5:30 PM ET (please note new start time) | |
| • | Dial-in Information:1-888-334-5785 | |
| • | Replay: Available on Friday, May 10, 2024 for 90 days at https://smartglass-ir.com/ | |
Key Comments:
| 1. | Fee income during the first quarter of 2024 increased by over |
| 2. | The Company expects revenue in all market segments to increase as new car models, aircraft, trains, architectural, information display and other products using the Company’s SPD-SmartGlass technology are introduced into the market. |
| 3. | At March 31, 2024, the Company had cash and cash equivalents of approximately |
For more details, please see the Company’s Quarterly Report on Form 10-Q which was filed today with the SEC, the contents of which are incorporated by reference herein.
About Research Frontiers
Research Frontiers (Nasdaq: REFR) is a publicly traded technology company and the developer of patented SPD-Smart light-control film technology which allows users to instantly, precisely and uniformly control the shading of glass or plastic products, either manually or automatically. Research Frontiers has licensed its smart glass technology to numerous companies that include well known chemical, material science and glass companies. Products using Research Frontiers’ smart glass technology are being used in tens of thousands of cars, aircraft, yachts, trains, homes, offices, museums and other buildings. For more information, please visit our website at www.SmartGlass.com, and on Facebook, Twitter, LinkedIn and YouTube.
Note: From time to time Research Frontiers may issue forward-looking statements which involve risks and uncertainties. This press release contains forward-looking statements. Actual results, especially those reliant on activities by third parties, could differ and are not guaranteed. Any forward-looking statements should be considered accordingly. “SPD-Smart” and “SPD-SmartGlass” are trademarks of Research Frontiers Inc.
CONTACT:
Joseph M. Harary
President and CEO
Research Frontiers Inc.
+1-516-364-1902
Info@SmartGlass.com
RESEARCH FRONTIERS INCORPORATED
Condensed Consolidated Balance Sheets
| March 31, 2024 (Unaudited) | December 31, 2023 (See Note 1) | |||||||
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 2,093,458 | $ | 2,475,958 | ||||
| Royalties receivable, net of reserves of | 956,783 | 1,003,404 | ||||||
| Prepaid expenses and other current assets | 240,771 | 96,784 | ||||||
| Total current assets | 3,291,012 | 3,576,146 | ||||||
| Fixed assets, net | 33,199 | 39,598 | ||||||
| Operating lease ROU assets | 142,972 | 178,715 | ||||||
| Deposits and other assets | 56,066 | 56,066 | ||||||
| Total assets | $ | 3,523,249 | $ | 3,850,525 | ||||
| Liabilities and Shareholders’ Equity | ||||||||
| Current liabilities: | ||||||||
| Current portion of operating lease liability | $ | 216,943 | $ | 212,359 | ||||
| Accounts payable | 171,239 | 50,880 | ||||||
| Accrued expenses | 51,270 | 14,192 | ||||||
| Total current liabilities | 439,452 | 277,431 | ||||||
| Operating lease liability, net of current portion | - | 55,363 | ||||||
| Total liabilities | 439,452 | 332,794 | ||||||
| Shareholders’ equity: | ||||||||
| Common stock, par value | 3,352 | 3,351 | ||||||
| Additional paid-in capital | 127,787,890 | 127,779,221 | ||||||
| Accumulated deficit | (124,707,445 | ) | (124,264,841 | ) | ||||
| Total shareholders’ equity | 3,083,797 | 3,517,731 | ||||||
| Total liabilities and shareholders’ equity | $ | 3,523,249 | $ | 3,850,525 | ||||
RESEARCH FRONTIERS INCORPORATED
Condensed Consolidated Statements of Operations
(Unaudited)
| Three months ended March 31, | ||||||||
| 2024 | 2023 | |||||||
| Fee income | $ | 313,378 | $ | 248,175 | ||||
| Operating expenses | 633,387 | 587,799 | ||||||
| Research and development | 149,741 | 149,222 | ||||||
| Total expenses | 783,128 | 737,021 | ||||||
| Operating loss | (469,750 | ) | (488,846 | ) | ||||
| Net investment income | 27,146 | 26,208 | ||||||
| Net loss | $ | (442,604 | ) | $ | (462,638 | ) | ||
| Basic and diluted net loss per common share | $ | (0.01 | ) | $ | (0.01 | ) | ||
| Weighted average number of common shares outstanding | 33,510,408 | 33,286,648 | ||||||
RESEARCH FRONTIERS INCORPORATED
Condensed Consolidated Statements of Shareholders’ Equity
(Unaudited)
For the three months ended March 31, 2023 and 2024
| Common Stock | Additional | Accumulated | ||||||||||||||||||
| Shares | Amount | Paid-in Capital | Deficit | Total | ||||||||||||||||
| Balance, January 1, 2023 | 33,150,396 | $ | 3,315 | $ | 127,150,027 | $ | (122,356,477 | ) | $ | 4,796,865 | ||||||||||
| Exercise of warrants | 358,891 | 36 | 484,466 | - | 484,502 | |||||||||||||||
| Net loss | - | - | - | (462,638 | ) | (462,638 | ) | |||||||||||||
| Balance, March 31, 2023 | 33,509,287 | $ | 3,351 | $ | 127,634,493 | $ | (122,819,115 | ) | $ | 4,818,729 | ||||||||||
| Common Stock | Additional | Accumulated | ||||||||||||||||||
| Shares | Amount | Paid-in Capital | Deficit | Total | ||||||||||||||||
| Balance, January 1, 2024 | 33,509,287 | $ | 3,351 | $ | 127,779,221 | $ | (124,264,841 | ) | $ | 3,517,731 | ||||||||||
| Exercise of options | 8,500 | 1 | 8,669 | - | 8,670 | |||||||||||||||
| Net loss | - | - | - | (442,604 | ) | (442,604 | ) | |||||||||||||
| Balance, March 31, 2024 | 33,517,787 | $ | 3,352 | $ | 127,787,890 | $ | (124,707,445 | ) | $ | 3,083,797 | ||||||||||
RESEARCH FRONTIERS INCORPORATED
Condensed Consolidated Statements of Cash Flows
(Unaudited)
| For the three months ended March 31, | ||||||||
| 2024 | 2023 | |||||||
| Cash flows from operating activities: | ||||||||
| Net loss | $ | (442,604 | ) | $ | (462,638 | ) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
| Depreciation and amortization | 6,449 | 6,816 | ||||||
| Unrealized gain on marketable securities | - | (22,900 | ) | |||||
| ROU asset amortization | 35,743 | 36,958 | ||||||
| Bad debt recovery | - | (5,000 | ) | |||||
| Change in assets and liabilities: | ||||||||
| Royalty receivables | 46,621 | (89,264 | ) | |||||
| Prepaid expenses and other assets | (143,987 | ) | 7,785 | |||||
| Accounts payable and accrued expenses | 157,437 | (33,288 | ) | |||||
| Deferred revenue | - | 11,921 | ||||||
| Operating lease liability | (50,779 | ) | (47,513 | ) | ||||
| Net cash used in operating activities | (391,120 | ) | (597,123 | ) | ||||
| Cash flows from investing activities: | ||||||||
| Purchases of fixed assets | (50 | ) | (702 | ) | ||||
| Purchases of marketable securities | - | (2,965,160 | ) | |||||
| Net cash used in investing activities | (50 | ) | (2,965,862 | ) | ||||
| Cash flows from financing activities: | ||||||||
| Net proceeds from exercise of options and warrants | 8,670 | 484,502 | ||||||
| Net cash provided by financing activities | 8,670 | 484,502 | ||||||
| Net decrease in cash and cash equivalents | (382,500 | ) | (3,078,483 | ) | ||||
| Cash and cash equivalents at beginning of period | 2,475,958 | 4,230,916 | ||||||
| Cash and cash equivalents at end of period | $ | 2,093,458 | $ | 1,152,433 | ||||
FAQ
What are Research Frontiers Inc.'s stock symbol and the date for hosting a conference call?
How much did fee income increase by in the first quarter of 2024?
What is Research Frontiers Inc.'s cash position as of March 31, 2024?
